Our team has recently published the first comprehensive overview of the status of health economics for medical devices and in-vitro diagnostics in China, "Health economic evaluations of medical devices in the People's Republic of China: A systematic literature review," in one of the leading European health economic journals - ClinicoEconomics and Outcomes Research.
NHS England has opened consultation on design of genetic testing service in England. The major innovation is introduction of the Genomics Centralised Laboratory Hubs.
Clinical commissioning policy determines framework for provision (target population, conditions, funding mechanisms, quality requirements) of the services in England. Current call for consultations covers bariatric surgery, PET-CT, proton beam radiotherapy, robot-assisted surgical procedures for cancer, cervical disk replacement, microprocessor-controlled knee prosthesis, deep brain stimulation for epilepsy and chronic pain, intrathecal pumps, genetic testing for BRCA1 and BRCA2 mutations, sacral nerve stimulation for urinary incontinence.
New report of the UK's charity organization in health care focuses of productivity in NHS system with a specific focus on hospitals. Authors predicted overspend of about £626m in 2014/15, despite substantial additional investments from Treasury and investments for capital equipment.
Italian health care budget is composed of regional and national resources. Economic constraints and the willingness to make Regions financially accountable for their planning decisions let the central government implement measures meant to reduce the role of central funding to the sole function of topping-up regional budgets. Read the post by our Market Access Analyst, Cristina Rao, about potential forthcoming changes affecting medical devices and envisaged by the Agreement between Regions and the central government currently under discussion in the Italian politics.
In coming months, the Italian healthcare system could face a major turning point in the reimbursement of out-patient specialist care. Italy is known as a market with quite static reimbursement system both for in- and out-patient services and no real ways to make changes in the system. Read analytical post by our Market Access Analyst, Cristina Rao, about forthcoming changes in Italian health care system.
Conferences & Events
In this webinar Dr Martin Braun will give a brief introduction to the German DRG system with a special focus on the innovation funding (NUB).
CEO Mattias Kyhlstedt will participate at the HTAi Meeting Global Efforts in Knowledge Transfer: HTA to Health Policy and Practice in Oslo.